Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Genitourinary 1

Conditions

Carcinoma, Transitional Cell 37Urinary Bladder Neoplasms 33Carcinoma, Renal Cell 30Carcinoma, Non-Small-Cell Lung 16Melanoma 15Prostatic Neoplasms 13Stomach Neoplasms 10Carcinoma, Hepatocellular 10Triple Negative Breast Neoplasms 9Kidney Neoplasms 9Colorectal Neoplasms 9Head and Neck Neoplasms 8Uterine Cervical Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Small Cell Lung Carcinoma 7Neoplasms 7Neoplasm Metastasis 6Lung Neoplasms 6Breast Neoplasms 6Ovarian Neoplasms 5Carcinoma, Merkel Cell 5Urologic Neoplasms 4Pancreatic Neoplasms 4Urethral Neoplasms 3Ureteral Neoplasms 3Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Sarcoma 2Prostatic Neoplasms, Castration-Resistant 2Neuroendocrine Tumors 2

Interventions

pembrolizumab 6Nivolumab 3Carboplatin 2spartalizumab 1regorafenib 1obinutuzumab 1naptumomab estafenatox 1liposomal doxorubicin 1enzalutamide 1durvalumab 1atezolizumab 1aflibercept 1abiraterone 1abemaciclib 1SGN-LIV1A 1Ritonavir 1Remote Patient Monitoring 1Paclitaxel 1NEO212 1Lopinavir 1Itraconazole 1Isotretinoin 1Ipilimumab 1Interferon-alpha 1Immunohistochemistry 1IFL protocol 1House Calls 1Home Care Services 1Gemcitabine 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × atezolizumab × Genitourinary × Clear all
NCT04713891 2024-09-24

A Study of KF-0210 in Advanced Solid Tumors Patients

Keythera (Suzhou) Pharmaceuticals Co. Ltd

Phase 1 Completed
14 enrolled
GastrointestinalGenitourinaryThoracic

Esophageal Squamous Cell Carcinoma, Urinary Bladder Neoplasms, Lung Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡